Related references
Note: Only part of the references are listed.Epigenetic regulation of hemoglobin switching in non-human primates
Robert Molokie et al.
SEMINARS IN HEMATOLOGY (2021)
Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy
Arushi Dhar et al.
BLOOD ADVANCES (2021)
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
Giorgio Milazzo et al.
GENES (2020)
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Fetal hemoglobin induction in sickle erythroid progenitors using a synthetic zinc finger DNA-binding domain
Biaoru Li et al.
HAEMATOLOGICA (2018)
A Phase 3 Trial of L-Glutamine in Sickle Cell Disease
Yutaka Niihara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition
Bo Jing et al.
CELL DEATH & DISEASE (2018)
Fetal hemoglobin induction in sickle erythroid progenitors using a synthetic zinc finger DNA-binding domain
Biaoru Li et al.
HAEMATOLOGICA (2018)
NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human erythroid progenitors
Xingguo Zhu et al.
HAEMATOLOGICA (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
K. I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human erythroid progenitors
Xingguo Zhu et al.
HAEMATOLOGICA (2017)
Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms
Yan Dai et al.
BLOOD CELLS MOLECULES AND DISEASES (2016)
Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Takeshi Masuda et al.
SCIENCE (2016)
Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation
Erica B. Esrick et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea
Maureen M. Okam et al.
BLOOD (2015)
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver et al.
NATURE (2015)
Epigenetic regulation of fetal globin gene expression in adult erythroid cells
Gordon D. Ginder
TRANSLATIONAL RESEARCH (2015)
Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia
Rajasekhar N. V. S. Suragani et al.
BLOOD (2014)
Targeted Fetal Hemoglobin Induction for Treatment of Beta Hemoglobinopathies
Susan P. Perrine et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Targeting a new regulator of erythropoiesis to alleviate anemia
Robert F. Paulson
NATURE MEDICINE (2014)
Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells
Maria Amaya et al.
BLOOD (2013)
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
Lihong Shi et al.
NATURE MEDICINE (2013)
Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Ryo Kurita et al.
PLOS ONE (2013)
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
Andrew Wilber et al.
BLOOD (2011)
Erythroid phenotypes associated with KLF1 mutations
Joseph Borg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
p66α-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex
Merlin Nithya Gnanapragasam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Clinical development of panobinostat in classical Hodgkin's lymphoma
Yasuhiro Oki et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice
Robert P. Hebbel et al.
BLOOD (2010)
KLF1 regulates BCL11A expression and γ- to β-globin gene switching
Dewang Zhou et al.
NATURE GENETICS (2010)
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
James E. Bradner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
BCL11A represses HBG transcription in K562 cells
Zhiyi Chen et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
Synthesis and Conformation-Activity Relationships of the Peptide Isosteres of FK228 and Largazole
Albert A. Bowers et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
BCL11A is a major HbF quantitative trait locus in three different populations with β-hemoglobinopathies
Amanda E. Sedgewick et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Total synthesis and biological mode of action of largazole: A potent Class I histone deacetylase inhibitor
Albert Bowers et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.
Kanchan Taori et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and Amelioration of the phenotype of β-thalassemia
Manuela Uda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves γ-globin activation by CREB1 and ATF-2
Jose Sangerman et al.
BLOOD (2006)
Methyl binding domain protein 2 mediates γ-globin gene silencing in adult human βYAC transgenic mice
JW Rupon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effects of 5-aza-2 '-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease
Y Saunthararajah et al.
BLOOD (2003)
Looping and interaction between hypersensitive sites in the active β-globin locus
B Tolhuis et al.
MOLECULAR CELL (2002)
Pharmacologic modulation of fetal hemoglobin
MH Steinberg et al.
MEDICINE (2001)
Share Paper
